Immunomedics, Inc. (IMMU) said Friday that it has priced its underwritten public offering of about 6.09 million shares of common stock, at a price to the public of $2.30 per share, resulting in gross proceeds of $14.0 million.
The offering is expected to close on or about February 27.
Immunomedics has granted the underwriters a 30 day option to purchase up to 913,044 additional shares of common stock to cover over-allotments, if any.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.